Stockhub

Pathfinder Cell Therapy, Inc.: Revision history

View logs for this page

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

29 August 2022

  • curprev 16:5016:50, 29 August 2022‎ Nick talk contribs‎ 613 bytes +613‎ Created page with "== Summary<ref>Source: Yahoo Finance.</ref> == Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. Th..." Tag: Visual edit: Switched
Retrieved from ‘https://stockhub.co/research/Pathfinder_Cell_Therapy,_Inc.’